🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Did you know that #NRGcc008 SOROCk patient forms are available is multiple languages? Ask your study site staff for more information and to connect you with the documents! #ovariancancerprevention #BRCA1

Catch up on all the updates about the @FORTEStudy in our April newsletter, including a webinar- POLYPS 101 - to be held on May 20th and led by study co-PI, Jeffrey M Dueker, MD, MPH. ow.ly/EAwG50VBQKw

Excited to take on this new role and follow in the footsteps of Jeff Bradley, MD!!

Why are brain metastases from small cell lung cancer the last hold out for stereotactic radiotherapy? Listen to NRG Oncology Podcast on why we are doing CC009. open.spotify.com/episode/5URmgM… Lauren Henke, MD, MSCI Vinai Gondi

For Clinical Trials Day 2025, we join our colleagues in #cancerresearch to honor the power & purpose of all clinical research professionals & a heartfelt thank you to patients everywhere who have participated or are participating in a #clinicaltrial. #ClinicalTrialsDay #CTD2025

Honoring the dedication of the amazing researchers committed to improving #clinicaltrials and outcomes. #Advocates appreciate you - part of my NRG Oncology podcast interview message 👇👇 #CTD2025

Advocating for pts is arguably the most important thing we do in cancer research. Listen to newest NRG Oncology podcast on what advocacy is all about w/ Tambre Leighn, MA, CPC she/her . open.spotify.com/episode/4E5CGQ… Lauren Henke, MD, MSCI Stephen Chun National Cancer Institute RTOG Foundation NSABP Foundation

We asked the study team to explain NRG-CC014, the PREEMPT Study, which recently activated & is now enrolling patients with high-risk bone asymptomatic metastases. ow.ly/TngB50VSJnK Sign up for the webinar to learn more about this trial. ⬇️ Erin Gillespie, MD MPH

Happy SOROCk’N Wednesday! When you have a patient with a BRCA1 mutation interested in this #clinicaltrial, how can you counsel them on what to expect? Following the chosen surgical procedure, the patient is followed once yearly for 20 yrs, incl an annual CA125 & online surveys.

At Chicago Symphony Orchestra hall with ASCO past president Sandra for Board of Director meeting. A toast to ending cancer as we know it! Georgetown University Georgetown Medicine Georgetown Lombardi

If you’re in Chicago drop by our presentations!

Put on your planner

NRG-BR003 results - the addition of carboplatin to weekly paclitaxel following DD AC for adjuvant node positive or high-risk N0 TNBC did not improve iDFS #ASCO25 #OncoAlert OncoAlert #BreastCancer

📌 NRG-BR003: A randomized phase Ill trial comparing doxorubicin plus cyclophosphamide followed by weekly paclitaxel with or without carboplatin for node-positive or high-risk node-negative TNBC. ✨Vicente Valero #ASCO25 OncoAlert #OncoAlertAF #Day3

Let’s Go!! 🔥 NRG Oncology National Cancer Institute NCICancerTrials #pancsm

Amazing hearing from Ryan Strandlund at #NRG25 Communications & Digital Engagement (CDE) Workshop How to utilize digital advocacy ASCO Kristin Higgins The Life Raft Group Sara Rothschild UCLA Health ASCO

The Pathology Committee session at #NRG2025 will be held in-person on Thursday, July 24. Details ⬇️

It's SOROCk’n Wednesday and almost time for #NRG2025 in Washington, DC! We are looking forward to seeing everyone in person! If you have questions about the SOROCk study, please reach out via DM, and the study team will connect with you.

The session is now over but will be on the NRG ONCOLOGY WEBSIT. There were 3 awesome speakers. Catch them on the the WEBSITE!

Excellent and all inspiring items which were presented at the Communications and Digital Engagement workshop at the virtual #NRG2025 summer pre-meeting virtual workshop. Did you miss it, then check the NRG website for it.